V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10387768 | 10040683 | null | null | null | null | 2019-09-06 | Busulfan Oral | 02 | N | TRIAL | 100697227 |
| 10387807 | 10040684 | 1.67 | 56.4 | Adjuvant (A) | 2019-01-04 | 2019-01-06 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100494608 |
| 10387846 | 10040685 | 1.55 | 93.7 | null | 2018-04-12 | 2018-04-24 | Avelumab | 02 | N | AVELUMAB | 101479460 |
| 10387850 | 10040686 | 1.81 | 84 | 02 | 2021-11-29 | 2021-11-30 | Cytarabine Low Dose | N | N | TRIAL | 100801955 |
| 10387965 | 10040688 | 0 | 0 | Curative (C) | 2017-02-22 | 2017-02-22 | Temozolomide 200mg/m2 | 02 | N | TEMOZOLOMIDE | 101679067 |
| 10388018 | 10040689 | 1.79 | 71.75 | Neo-adjuvant (N) | 2018-12-05 | 2018-12-27 | CAPECITABINE + GEMCITABINE | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101054566 |
| 10388109 | 10040690 | 1.67 | 62.8 | null | 2019-05-04 | 2019-05-07 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100879843 |
| 10388184 | 10040692 | 1.84 | 60 | null | 2019-06-03 | 2019-06-03 | null | 02 | Y | CLADRIBINE | 100641963 |
| 10388212 | 10040694 | 1.68 | 63.8 | Adjuvant (A) | 2010-09-01 | 2020-01-19 | CHOP R - 21 days | 02 | N | CHOP R | 100539760 |
| 10388255 | 10040695 | null | 74.8 | Palliative (P) | 2019-08-11 | 2019-08-25 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100073944 |
| 10388297 | 10040696 | 1.78 | 108 | Adjuvant (A) | 2019-12-23 | 2020-01-05 | Venetoclax | 02 | null | CYTARABINE | 101333234 |
| 10388341 | 10040697 | 1.72 | null | Palliative (P) | 2017-11-27 | 2017-12-16 | FEC 60 or 75 | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100120971 |
| 10388370 | 10040699 | null | null | 03 | 2020-10-27 | 2020-11-02 | Cyclophosphamide + Docetaxel | 02 | N | TRIAL | 100326143 |
| 10388411 | 10040700 | 1.58 | 49.6 | Palliative (P) | 2019-04-23 | 2019-04-23 | CTD Attenuated (Thalidomide 50mg) | null | N | BUSULFAN | 100296978 |
| 10388440 | 10040701 | 1.55 | 74.4 | null | 2020-05-28 | 2020-06-01 | Cytarabine Low Dose | N | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101539323 |
| 10388489 | 10040702 | 1.57 | 58.5 | Palliative (P) | 2016-11-16 | 2016-11-18 | Temozolomide 150mg/m2 | 02 | N | TEMOZOLOMIDE | 100070013 |
| 10388525 | 10040703 | 1.71 | 63 | null | 2019-08-25 | 2019-09-08 | Temozolomide 150mg/m2 | 02 | null | TEMOZOLOMIDE | 101203313 |
| 10388541 | 10040704 | 1.68 | 0 | Palliative (P) | 2019-11-25 | 2019-12-23 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE | 101400304 |
| 10388558 | 10040705 | 1.66 | 53.8 | Curative (C) | 2019-04-03 | 2019-04-12 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100157464 |
| 10388574 | 10040706 | 1.65 | 74.4 | Curative (C) | 2020-04-17 | 2020-04-18 | DABRAFENIB + TRAMETINIB | 02 | N | CISPLATIN + FLUOROURACIL | 101763942 |
| 10388605 | 10040707 | 1.62 | 69.4 | Disease modification (D) | 2019-09-17 | 2019-09-28 | Acalabrutinib | 02 | N | ACALABRUTINIB | 101429263 |
| 10388815 | 10040711 | 1.66 | 64 | null | 2017-10-14 | 2017-10-28 | Capecitabine + Cisplatin | N | null | CISPLATIN + VINORELBINE | 101530889 |
| 10388828 | 10040712 | 1.68 | 83.8 | Neo-adjuvant (N) | 2019-04-25 | 2019-05-01 | BORTEZOMIB + THALIDOMIDE | 02 | N | BORTEZOMIB + THALIDOMIDE | 100260280 |
| 10388834 | 10040713 | 1.6 | 68.8 | Palliative (P) | 2017-03-08 | 2017-03-13 | Palbociclib | 02 | N | PALBOCICLIB | 101773311 |
| 10388861 | 10040714 | 1.79 | 51.2 | Adjuvant (A) | 2018-01-09 | 2018-01-15 | Palbociclib | 02 | N | PALBOCICLIB | 101616462 |
| 10389033 | 10040716 | 1.56 | 0 | 03 | 2016-10-06 | 2016-10-19 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100759460 |
| 10389050 | 10040717 | 1.63 | 63.7 | Palliative (P) | 2020-02-11 | 2020-03-01 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | N | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100907314 |
| 10389116 | 10040718 | 1.6 | 56.2 | Palliative (P) | 2018-10-10 | 2018-10-25 | Cyclophosphamide + Docetaxel | N | N | CLADRIBINE | 101678134 |
| 10389223 | 10040719 | 1.7 | 88 | null | 2017-12-31 | 2018-01-15 | CHLORAMBUCIL + RITUXIMAB | 02 | null | CHLORAMBUCIL + RITUXIMAB | 100225797 |
| 10389299 | 10040720 | 1.52 | 71.45 | null | 2019-12-21 | 2019-12-22 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 101126989 |
| 10389303 | 10040721 | null | 105 | null | 2019-01-04 | 2019-01-04 | R Chlorambucil | 02 | null | CHLORAMBUCIL + RITUXIMAB | 101789811 |
| 10389363 | 10040724 | 1.5 | 70.1 | Adjuvant (A) | 2018-09-12 | 2018-09-18 | Acalabrutinib | 02 | N | ACALABRUTINIB | 100389474 |
| 10389518 | 10040727 | 1.72 | 56 | Adjuvant (A) | 2019-05-25 | 2019-06-01 | CISPLATIN + FLUOROURACIL | 02 | N | CAPECITABINE + GEMCITABINE | 100627583 |
| 10389528 | 10040728 | 1.58 | 68.8 | Neo-adjuvant (N) | 2017-09-23 | 2017-09-24 | DARATUMUMAB | 02 | N | CLADRIBINE | 101248608 |
| 10389602 | 10040729 | 0 | 90 | Neo-adjuvant (N) | 2019-03-30 | 2019-04-01 | CHOP R | 02 | N | CHOP R | 100083982 |
| 10389680 | 10040730 | 1.81 | 87 | Curative (C) | 2019-07-06 | 2019-07-26 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 101663957 |
| 10389792 | 10040732 | null | null | Adjuvant (A) | 2018-10-24 | 2018-11-08 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101851614 |
| 10389797 | 10040734 | 1.67 | 78.4 | Adjuvant (A) | 2019-06-28 | 2019-06-28 | CISPLATIN + FLUOROURACIL | 02 | N | CVP R | 100984617 |
| 10389868 | 10040735 | 1.53 | 94 | Disease modification (D) | 2017-06-09 | 2017-06-12 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101385289 |
| 10390012 | 10040739 | 1.7 | 85 | Palliative (P) | 2019-01-18 | 2019-01-24 | BORTEZOMIB + THALIDOMIDE | N | Y | BORTEZOMIB + THALIDOMIDE | 101020563 |
| 10390065 | 10040740 | 0 | 81 | 03 | 2019-01-14 | 2019-01-30 | Bortezomib +/- Dexamethasone | 02 | N | POMALIDOMIDE | 101295404 |
| 10390107 | 10040741 | 1.72 | 78 | Palliative (P) | 2018-03-23 | 2018-03-30 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101389682 |
| 10390163 | 10040742 | 1.67 | 72 | Unknown (U) | 2018-07-26 | 2018-08-21 | FEC 100 + DOCETAXEL | 02 | N | CISPLATIN + FLUOROURACIL | 100682907 |
| 10390166 | 10040743 | null | 63 | 03 | 2018-02-19 | 2018-02-19 | Carboplatin + Vinorelbine IV | 02 | N | CARBOPLATIN + VINORELBINE | 100576185 |
| 10390353 | 10040746 | 1.56 | 82.6 | Neo-adjuvant (N) | 2017-09-28 | 2017-10-25 | CHOP | null | N | CYTARABINE | 100422992 |
| 10390440 | 10040748 | 1.7 | 67.8 | null | 2020-05-06 | 2020-05-06 | IPILIMUMAB + NIVOLUMAB | N | null | IPILIMUMAB + NIVOLUMAB | 100122728 |
| 10390471 | 10040749 | 1.55 | 105.8 | Curative (C) | 2018-04-16 | 2018-05-03 | BUSULFAN | 02 | null | VENETOCLAX | 100394158 |
| 10390473 | 10040750 | 1.75 | 87 | 03 | 2016-11-20 | 2016-11-20 | FEC 60 or 75 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101807300 |
| 10390535 | 10040751 | 1.6 | 73.1 | null | 2000-06-22 | 2020-07-05 | Folfirinox | null | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100994518 |
| 10390565 | 10040753 | 1.82 | 75.8 | Palliative (P) | 2017-12-27 | 2017-12-28 | Carboplatin + Vinorelbine Oral | 02 | N | CARBOPLATIN + VINORELBINE | 100055524 |